169 related articles for article (PubMed ID: 37261965)
1. Smooth Muscle Tumors of the Uterus at MRI: Focus on Leiomyomas and FIGO Classification.
Tu W; Yano M; Schieda N; Krishna S; Chen L; Gottumukkala RV; Alencar R
Radiographics; 2023 Jun; 43(6):e220161. PubMed ID: 37261965
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound features of highly vascularized uterine myomas (uterine smooth muscle tumors) and correlation with histopathology.
Russo C; Camilli S; Martire FG; Di Giovanni A; Lazzeri L; Malzoni M; Zupi E; Exacoustos C
Ultrasound Obstet Gynecol; 2022 Aug; 60(2):269-276. PubMed ID: 35018681
[TBL] [Abstract][Full Text] [Related]
3. MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.
Bura V; Pintican RM; David RE; Addley HC; Smith J; Jimenez-Linan M; Lee J; Freeman S; Georgiu C
Br J Radiol; 2021 Sep; 94(1125):20210283. PubMed ID: 34289327
[TBL] [Abstract][Full Text] [Related]
4. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
5. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
6. Uterine smooth muscle tumours with hyperintense area on T
Ando T; Kato H; Furui T; Morishige KI; Goshima S; Matsuo M
Br J Radiol; 2018 Apr; 91(1084):20170767. PubMed ID: 29308922
[TBL] [Abstract][Full Text] [Related]
7. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
8. EMMPRIN (CD147) Expression in Smooth Muscle Tumors of the Uterus.
Kefeli M; Yildiz L; Gun S; Ozen FZ; Karagoz F
Int J Gynecol Pathol; 2016 Jan; 35(1):1-7. PubMed ID: 26352545
[TBL] [Abstract][Full Text] [Related]
9. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
[TBL] [Abstract][Full Text] [Related]
10. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
Schwetye KE; Pfeifer JD; Duncavage EJ
Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 Expression and Tumor-infiltrating Lymphocytes in Uterine Smooth Muscle Tumors: Implications for Immunotherapy.
Shanes ED; Friedman LA; Mills AM
Am J Surg Pathol; 2019 Jun; 43(6):792-801. PubMed ID: 31009388
[TBL] [Abstract][Full Text] [Related]
12. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
[TBL] [Abstract][Full Text] [Related]
13. An unusual case of uterine cotyledonoid dissecting leiomyoma with adenomyosis.
Shimizu A; Tanaka H; Iwasaki S; Wakui Y; Ikeda H; Suzuki A
Diagn Pathol; 2016 Aug; 11(1):69. PubMed ID: 27491369
[TBL] [Abstract][Full Text] [Related]
14. Validating the diagnostic accuracy of an MRI-based scoring system for differentiating benign uterine leiomyomas from leiomyosarcomas.
Al Khuri M; Al Salmi I; Al Ajmi H; Al Hadidi A; Alabousi A; Haider E; Vasudev P; Al Salmi A; Jose S; Alrahbi N
Int J Gynecol Cancer; 2024 Jul; 34(7):1027-1033. PubMed ID: 38658016
[TBL] [Abstract][Full Text] [Related]
15. Value of ultrasonography and magnetic resonance imaging for the characterization of uterine mesenchymal tumors.
Bonneau C; Thomassin-Naggara I; Dechoux S; Cortez A; Darai E; Rouzier R
Acta Obstet Gynecol Scand; 2014 Mar; 93(3):261-8. PubMed ID: 24372487
[TBL] [Abstract][Full Text] [Related]
16. [Uterine smooth muscle tumors: retrospective epidemiological and pathological study of 2760 cases].
Rammeh-Rommani S; Mokni M; Stita W; Trabelsi A; Hamissa S; Sriha B; Tahar-Yacoubi M; Korbi S
J Gynecol Obstet Biol Reprod (Paris); 2005 Oct; 34(6):568-71. PubMed ID: 16208199
[TBL] [Abstract][Full Text] [Related]
17. Smooth muscle tumours of the uterus: MR imaging malignant predictive features-a 12-year analysis in a referral hospital in Portugal.
Freitas P; Resende-Neves T; Lameira P; Costa M; Dias P; Filipe J; Ferreira J; Félix A; Cunha TM
Arch Gynecol Obstet; 2024 Apr; 309(4):1551-1560. PubMed ID: 38055011
[TBL] [Abstract][Full Text] [Related]
18. Quantitative MR texture analysis for the differentiation of uterine smooth muscle tumors with high signal intensity on T2-weighted imaging.
Kumagai K; Yagi T; Yamazaki M; Tasaki A; Asatani M; Ishikawa H
Medicine (Baltimore); 2023 Aug; 102(31):e34452. PubMed ID: 37543807
[TBL] [Abstract][Full Text] [Related]
19. Variant type of leiomyomas: 13 years of experience in a single institution.
Bacanakgil BH; Ilhan G; Kaban I
Ginekol Pol; 2022; 93(6):444-449. PubMed ID: 34155617
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]